I 118th CONGRESS 2d Session H. R. 7248 IN THE HOUSE OF REPRESENTATIVES February 6, 2024 Mr. Carter of Georgia (for himself, Ms. Barragán , Mrs. Harshbarger , Mr. Buchanan , Mr. Carter of Louisiana , Mr. Waltz , Ms. DeLauro , Mr. Nehls , Mr. Gooden of Texas , Mr. Crenshaw , and Mr. Fitzpatrick ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to establish a process for the qualification of nonclinical testing methods to reduce and replace the use of animals in nonclinical research, improve the predictivity of nonclinical testing methods, and reduce development time for a biological product or other drug, and for other purposes.